As Toujeo (insulin glargine U300)has a longer action the same amount of insulin is spread over a longer period of time. This results in a higher dose of insulin needed with Toujeo(U300) as compared to Lantus(U100). In clinical studies people on Toujeo (U300) required 10-20% more insulin compared to Lantus insulin.